Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Emiddio, Barletta"'
Autor:
Vincenzo Ricci, Teresa Fabozzi, Maria Anna Bareschino, Emiddio Barletta, Domenico Germano, Immacolata Paciolla, Vincenza Tinessa, Antonio Maria Grimaldi
Publikováno v:
Journal of Personalized Medicine. 12:2076
Pancreatic cancer is the fourth-leading cause of cancer-related deaths worldwide. The outcomes in patients with pancreatic cancer remain unsatisfactory. In the current review, we summarize the genetic and epigenetic architecture of metastatic pancrea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93e93cb0c841889fe0d7c4622d6e9486
https://doi.org/10.3390/jpm12122076
https://doi.org/10.3390/jpm12122076
Autor:
Francesco Perrone, Domenico Galetta, Maria Carmela Piccirillo, Francesco Ferraù, Emiddio Barletta, Gerardo Botti, Francesca Fenizia, Elisabetta Sara Montagna, Vienna Ludovini, Lucio Crinò, Antonella De Luca, Matilde Lambiase, Cristin Roma, Anna Maria Rachiglio, Agnese Montanino, Gaetano Rocco, Carmine Pinto, Nicola Normanno, Bruno Vincenzi, Alessandro Morabito
Publikováno v:
Cancers, Vol 11, Iss 3, p 341 (2019)
Cancers
Volume 11
Issue 3
Cancers
Volume 11
Issue 3
Recent findings suggest that a fraction of EGFR-mutant non-small-cell lung cancers (NSCLC) carry additional driver mutations that could potentially affect the activity of EGFR tyrosine kinase inhibitors (TKIs). We investigated the role of concomitant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f6dc9a1276455e020cefec58eb631c8
http://www.mdpi.com/2072-6694/11/3/341
http://www.mdpi.com/2072-6694/11/3/341
Autor:
Vincenza Tinessa, Domenico Germano, Bruno Daniele, Lucia Cannella, Emiddio Barletta, Teresa Pironti, Piera Federico
Publikováno v:
Molecular and clinical oncology. 7(5)
Non-small-cell lung cancer (NSCLC) is the most common malignancy in industrialized countries, with a 5-year survival rate of only ~15%, as the majority of the patients have advanced-stage disease at diagnosis and the treatment options are limited. Sq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1133fddedc4dadab2d09093302fd824
https://pubmed.ncbi.nlm.nih.gov/29142753
https://pubmed.ncbi.nlm.nih.gov/29142753
Publikováno v:
Case Reports in Clinical Medicine. :373-377
K-ras wild-type carcinoma is a tumour that is sensitive to treatment with anti-cancer and anti-EGFR drugs: the combination of Cetuximab and Panitumumab with chemotherapy (Cetuximab) or as a single therapy (Panitumumab). Case Report: The clinical case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d75440439ed7ea2a19b1e5c6582462ad
https://doi.org/10.4236/crcm.2014.36083
https://doi.org/10.4236/crcm.2014.36083
Publikováno v:
Hepatology Research. 37:S206-S209
Aim: To assess the prognostic ability of the Cancer of the Liver Italian Program (CLIP) score in patients with hepatocellular carcinoma after a longer follow up. Methods: The updated survival data were derived from an analysis that was performed on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4052654c33836c7bcd3676069cf76f93
https://doi.org/10.1111/j.1872-034x.2007.00186.x
https://doi.org/10.1111/j.1872-034x.2007.00186.x
Autor:
Gridelli C., Gallo C., Morabito A., Iaffaioli R. V., Favaretto A., Isa L., Barbera S., Gamucci T., Ceribelli A., Filipazzi V., Maione P., Rossi A., Barletta E., Signoriello S., De Maio E., Piccirillo M. C., Di Maio M., Rocco G., Vecchione A., Perrone F., Cesare Gridelli, Paolo Maione, Antonio Rossi, Ciro Gallo, Giuseppe Signoriello, Paolo Chiodini, Simona Signoriello, Francesco Perrone, Massimo Di Maio, Maria Carmela Piccirillo, Ermelinda De Maio, Jane Bryce, Alessandro Morabito, Raffaele Costanzo, Gaetano Rocco, Rosario Vincenzo Iaffaioli, Emiddio Barletta, Roberta Formato, Aldo Vecchione, Adolfo Favaretto, Giulia Pasello, Cristina Magro, Luciano Isa, Raffaele Venezia, Mario Comandè, Santi Barbera, Francesco Renda, Antonio Volpintesta, Teresa Gamucci, Maria Anna Giampaolo, Giovanni Mansueto, Anna Ceribelli, Ilaria Carbone, Domenica Pellegrini, Virginio Filipazzi, Elena Piazza, Sabrina Ferrario, Vittorina Zagonel, Giuditta di Isernia, Marco Ciaparrone, Francovito Piantedosi, Fabiana Vitiello, Nicolò Borsellino, Maria Elia Vitale, Luigi Brancaccio, Sergio Spina, Maria Rosaria Valerio, Raffaella Felletti, Salvatore Tafuto, Marianna Giampaglia, Rita Migliorino, Francesco Rosetti, Francesco Carrozza, Nestore Rossi, Mario Spatafora, Manlio Mencoboni, Ernest Marshall
Introduction: Treatment of elderly patients with small cell lung cancer (SCLC) is based on scanty evidence. Methods: Patients with extensive SCLC, age >70 years, and performance status 0-2 were eligible for a study looking for optimal two-drug combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c287ad1d0d718db86daca9f97723eed4
http://hdl.handle.net/2318/150674
http://hdl.handle.net/2318/150674
Autor:
Emiddio Barletta, Francesco Perrone, Roberto D'Angelo, Rosario Vincenzo Iaffaioli, Ermelinda De Maio, Francesco Fiore, Sandro Pignata, Bruno Daniele
Publikováno v:
Critical Reviews in Oncology/Hematology. 46:285-295
Background: Transcatheter arterial procedures (TAP) have been widely used to treat hepatocellular carcinoma (HCC) in several clinical settings (advanced and neoadjuvant), and contraindications and secondary effects have been clearly described. Howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed3c5251cd9d939fea82c8b39ca978c
https://doi.org/10.1016/s1040-8428(02)00175-0
https://doi.org/10.1016/s1040-8428(02)00175-0
Autor:
Carmela Pisano, Gerardo Botti, Emiddio Barletta, Cesare Gridelli, Vincenzo Rosario Iaffaioli, Anna De Chiara, Paolo A. Ascierto, Alessandro Ottaiano, Gaetano Apice
Publikováno v:
Scopus-Elsevier
Background CD40, a cell surface molecule, is expressed on B-cell malignancies and many different solid tumors. It is capable of mediating diverse biological phenomena such as the induction of apoptosis in tumors and stimulation of the immune response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85659a2eb762032561025834248dc1de
https://doi.org/10.1177/030089160208800502
https://doi.org/10.1177/030089160208800502
Autor:
M L Barzelloni, R. Cioffi, C. Gridelli, A. Rossi, F. Perrone, Luciano Frontini, Enzo Veltri, M Grazia Caprio, Ciro Gallo, Domenico Bilancia, Emiddio Barletta, Luigi Manzione
Publikováno v:
British Journal of Cancer
A multicentre phase 2 trial (single-stage design) was undertaken to test the efficacy and toxicity of carboplatin (AUC 6 according to Calvert) plus paclitaxel (175 mg/m23-h infusion) every 4 weeks in the first line treatment of patients affected by e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470709726d96dbf5df7d7f684d3926eb
https://doi.org/10.1054/bjoc.2000.1541
https://doi.org/10.1054/bjoc.2000.1541
Autor:
Emiddio Barletta, C. Guida, M L Barzelloni, Roberta D’Aniello, Cesare Gridelli, Francesco Fiore, Tindaro Gatani, Mario De Bellis, Antonio Rossi, Francesco Scognamiglio
Publikováno v:
Lung Cancer. 29:131-137
Experimental studies have shown that vinorelbine is a powerful radiosensitizer in vitro. To date, no reports on clinical activity of the single agent vinorelbine as radiosensitizer have been published. The aim of the present phase I study was to dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b21c34dde3539ce4d6b938860698138
https://doi.org/10.1016/s0169-5002(00)00102-1
https://doi.org/10.1016/s0169-5002(00)00102-1